Kennedy Capital Management LLC Has $2.66 Million Stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Kennedy Capital Management LLC raised its stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 49.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 41,461 shares of the company's stock after purchasing an additional 13,653 shares during the period. Kennedy Capital Management LLC's holdings in Ryan Specialty were worth $2,660,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Vanguard Group Inc. increased its holdings in Ryan Specialty by 5.7% in the 4th quarter. Vanguard Group Inc. now owns 9,880,504 shares of the company's stock valued at $633,933,000 after buying an additional 529,631 shares during the period. Bessemer Group Inc. lifted its stake in Ryan Specialty by 2.5% during the fourth quarter. Bessemer Group Inc. now owns 3,283,216 shares of the company's stock worth $210,651,000 after purchasing an additional 79,976 shares during the period. Blair William & Co. IL grew its stake in shares of Ryan Specialty by 0.6% in the 4th quarter. Blair William & Co. IL now owns 2,765,963 shares of the company's stock valued at $177,464,000 after purchasing an additional 16,540 shares during the period. Principal Financial Group Inc. raised its holdings in shares of Ryan Specialty by 115.2% in the 4th quarter. Principal Financial Group Inc. now owns 1,833,209 shares of the company's stock worth $117,619,000 after buying an additional 981,505 shares in the last quarter. Finally, Geode Capital Management LLC lifted its position in shares of Ryan Specialty by 2.7% during the 4th quarter. Geode Capital Management LLC now owns 1,799,130 shares of the company's stock worth $115,468,000 after buying an additional 46,960 shares during the period. 84.82% of the stock is currently owned by institutional investors and hedge funds.

Ryan Specialty Trading Down 2.0 %

Shares of RYAN stock traded down $1.46 on Friday, reaching $70.63. 967,494 shares of the stock were exchanged, compared to its average volume of 942,994. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. Ryan Specialty Holdings, Inc. has a one year low of $48.48 and a one year high of $77.16. The stock has a market cap of $18.50 billion, a PE ratio of 102.37, a P/E/G ratio of 1.19 and a beta of 0.66. The stock has a 50 day moving average price of $70.38 and a 200 day moving average price of $69.02.

Ryan Specialty (NYSE:RYAN - Get Free Report) last announced its quarterly earnings data on Thursday, February 20th. The company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.47 by ($0.02). Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The firm had revenue of $663.53 million for the quarter, compared to the consensus estimate of $658.80 million. Equities research analysts forecast that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Tuesday, March 4th were paid a $0.12 dividend. The ex-dividend date was Tuesday, March 4th. This is a boost from Ryan Specialty's previous quarterly dividend of $0.11. This represents a $0.48 dividend on an annualized basis and a yield of 0.68%. Ryan Specialty's dividend payout ratio (DPR) is presently 69.57%.

Insiders Place Their Bets

In other news, EVP Brendan Martin Mulshine sold 30,000 shares of the business's stock in a transaction dated Friday, March 14th. The stock was sold at an average price of $69.30, for a total transaction of $2,079,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Nicholas Dominic Cortezi sold 35,000 shares of the stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $66.35, for a total transaction of $2,322,250.00. Following the completion of the sale, the director now owns 20,909 shares in the company, valued at $1,387,312.15. This represents a 62.60 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 141,894 shares of company stock valued at $9,429,470. Company insiders own 11.10% of the company's stock.

Analyst Ratings Changes

A number of analysts have weighed in on the company. UBS Group upped their price target on Ryan Specialty from $82.00 to $84.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. Wells Fargo & Company dropped their target price on shares of Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating for the company in a research report on Thursday, April 10th. Keefe, Bruyette & Woods reduced their price target on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 9th. TD Cowen assumed coverage on shares of Ryan Specialty in a report on Thursday, April 10th. They set a "buy" rating and a $89.00 price objective for the company. Finally, Barclays cut their target price on shares of Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating for the company in a research note on Friday, April 11th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and seven have issued a buy rating to the company's stock. According to MarketBeat, Ryan Specialty has an average rating of "Hold" and an average price target of $75.67.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.